1h Free Analyst Time
The ursodeoxycholic acid market is forecasted to grow by USD 463.2 million during 2023-2028, accelerating at a CAGR of 12.16% during the forecast period. The report on the ursodeoxycholic acid market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of liver transplants, increasing incidence of primary sclerosing cholangitis and associated diseases, and expansion of indications for udca.
The ursodeoxycholic acid market is segmented as below:
By Type
- Synthetic ursodeoxycholic acid
- Extraction ursodeoxycholic acid
By Application
- Pharmacy products
- Health products
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the ursodeoxycholic acid market covers the following areas:
- Ursodeoxycholic acid market sizing
- Ursodeoxycholic acid market forecast
- Ursodeoxycholic acid market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global ursodeoxycholic acid market: Abil Chempharma Pvt. Ltd., Anant Pharmaceuticals Pvt. Ltd., Axplora, Cerata Pharmaceuticals LLP, Changde Yungang Biotechnology Co. Ltd., Daewoong Bio Inc., Dipharma Francis S.r.l., Glenmark Pharmaceuticals Ltd., ICE S.p.a., JSC Grindeks, Kimia Biosciences Ltd., Merck KGaA, Mitsubishi Chemical Group Corp., Octavius Pharma Pvt. Ltd., Osmopharm SA, Panjin Hengchanglong Pharmaceutical Co. Ltd., Suzhou Tianlu Bio Pharmaceutical Co. Ltd., Tianjin NWS Biotechnology and Medicine Co. Ltd., Travere Therapeutics Inc., and Zhongshan Belling Biotechnology Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for combination therapies."
According to the report, one of the major drivers for this market is the rise in number of liver transplants.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abil Chempharma Pvt. Ltd.
- Anant Pharmaceuticals Pvt. Ltd.
- Axplora
- Cerata Pharmaceuticals LLP
- Changde Yungang Biotechnology Co. Ltd.
- Daewoong Bio Inc.
- Dipharma Francis S.r.l.
- Glenmark Pharmaceuticals Ltd.
- ICE S.p.a.
- JSC Grindeks
- Kimia Biosciences Ltd.
- Merck KGaA
- Mitsubishi Chemical Group Corp.
- Octavius Pharma Pvt. Ltd.
- Osmopharm SA
- Panjin Hengchanglong Pharmaceutical Co. Ltd.
- Suzhou Tianlu Bio Pharmaceutical Co. Ltd.
- Tianjin NWS Biotechnology and Medicine Co. Ltd.
- Travere Therapeutics Inc.
- Zhongshan Belling Biotechnology Co. Ltd.
